Amgen 🧪🔬🧬(@Amgen):#NEWS: At #ESMO26, Amgen presents late-breaking data for our DLL3-targeting T-cell engager, with findings simultaneously published in @NEJM. These landmark results add to our growing body of evidence across the #SCLC treatment journey. Read more: https://t.co/GHl5SL1Que $AMGN

Amgen 🧪🔬🧬

@Amgen

Amgen harnesses the best of biology and technology to fight the world’s toughest diseases. 🔗 Guidelines:

加入 April 2009

963 正在關注 118.5K 粉絲

Amgen 🧪🔬🧬@Amgen

2026.10.24 14:45

#NEWS#: At #ESMO26#, Amgen presents late-breaking data for our DLL3-targeting T-cell engager, with findings simultaneously published in @NEJM. These landmark results add to our growing body of evidence across the #SCLC# treatment journey. Read more: $AMGN